180 related articles for article (PubMed ID: 10344634)
1. Simple O-acylated derivatives of lysergol and dihydrolysergol-I: synthesis and interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha1 adrenergic receptors.
Pertz HH; Brown AM; Gager TL; Kaumann AJ
J Pharm Pharmacol; 1999 Mar; 51(3):319-30. PubMed ID: 10344634
[TBL] [Abstract][Full Text] [Related]
2. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
Pertz HH; Milhahn H; Eich E
J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring clavines: antagonism/partial agonism at 5-HT2A receptors and antagonism at alpha 1-adrenoceptors in blood vessels.
Pertz H
Planta Med; 1996 Oct; 62(5):387-92. PubMed ID: 8923801
[TBL] [Abstract][Full Text] [Related]
4. O-acylated lysergol and dihydrolysergol-I derivatives as competitive antagonists of 5-HT at 5-HT2 receptors of rat tail artery. Allosteric modulation instead of pseudoirreversible inhibition.
Pertz H; Eich E
Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):394-401. PubMed ID: 1320207
[TBL] [Abstract][Full Text] [Related]
5. Complex interaction of ergovaline with 5-HT2A, 5-HT1B/1D, and alpha1 receptors in isolated arteries of rat and guinea pig.
Schöning C; Flieger M; Pertz HH
J Anim Sci; 2001 Aug; 79(8):2202-9. PubMed ID: 11518230
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the beta adrenergic receptor antagonist bucindolol with serotonergic receptors.
Watts SW; Fink GD; Silver PJ; Cushing DJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):29-36. PubMed ID: 10630730
[TBL] [Abstract][Full Text] [Related]
7. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
8. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
[TBL] [Abstract][Full Text] [Related]
10. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.
Fiorella D; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 May; 119(2):222-30. PubMed ID: 7659770
[TBL] [Abstract][Full Text] [Related]
11. Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat.
Maurel S; Schreiber R; De Vry J
Behav Pharmacol; 1998 Jul; 9(4):337-43. PubMed ID: 10065922
[TBL] [Abstract][Full Text] [Related]
12. Atypical sympathomimetic drug lerimazoline mediates contractile effects in rat aorta predominantly by 5-HT2A receptors.
Rizvić E; Janković G; Kostić-Rajačić S; Savić MM
Bosn J Basic Med Sci; 2017 Aug; 17(3):194-202. PubMed ID: 28628756
[TBL] [Abstract][Full Text] [Related]
13. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
Fitzgerald LW; Conklin DS; Krause CM; Marshall AP; Patterson JP; Tran DP; Iyer G; Kostich WA; Largent BL; Hartig PR
J Neurochem; 1999 May; 72(5):2127-34. PubMed ID: 10217294
[TBL] [Abstract][Full Text] [Related]
14. Activities of novel aryloxyalkylimidazolines on rat 5-HT2A and 5-HT2C receptors.
Siegel BW; Freedman J; Vaal MJ; Baron BM
Eur J Pharmacol; 1996 Feb; 296(3):307-18. PubMed ID: 8904083
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of a wide array of ergolines at functional alpha(1)-adrenoceptor subtypes.
Görnemann T; Jähnichen S; Schurad B; Latté KP; Horowski R; Tack J; Flieger M; Pertz HH
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jan; 376(5):321-30. PubMed ID: 18066532
[TBL] [Abstract][Full Text] [Related]
17. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
18. 5-HT receptors mediating contraction in the rat-tail artery.
Froldi G; Nicoletti P; Caparrotta L; Ragazzi E
Adv Exp Med Biol; 2003; 527():665-70. PubMed ID: 15206788
[TBL] [Abstract][Full Text] [Related]
19. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone.
Oekelen DV; Jurzak M; Van de Wiel D; Van Hecke G; Luyten WH; Leysen JE
Eur J Pharmacol; 2001 Aug; 425(1):21-32. PubMed ID: 11672571
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
